+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Postoperative Pain Therapeutics Market - Global Industry Analysis, Share, Growth, Trends, and Forecast, 2019 - 2027

  • ID: 4851359
  • Report
  • June 2019
  • Region: Global
  • 207 pages
  • Transparency Market Research
1 of 2

he global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the postoperative pain therapeutics market offers an extensive analysis of how the postoperative pain therapeutics landscape would evolve through 2027.

The research study on the postoperative pain therapeutics market analyzes key drivers upholding product sales and prominent trends shaping the growth of the postoperative pain therapeutics market. The research study not only focuses on the latent opportunities for the key stakeholders of the postoperative pain therapeutics market, but also sheds light on the notable developments and future scope for innovation in the postoperative pain therapeutics landscape.

The report starts off with a quick executive summary, wherein, key takeaways have been highlighted for the readers to have a sneak peak at the key market segments. The research study on the postoperative pain therapeutics market also talks about the macroeconomic and microeconomic factors having deep-rooted influences on global market growth. The research study on the postoperative pain therapeutics market also offers a regional analysis, wherein, demand across every region has been comprehensively analyzed.

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Postoperative Pain Therapeutics Market - Key Questions Answered in the Report

The report on the postoperative pain therapeutics market addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the postoperative pain therapeutics market report include-

  • What is the overall structure of the postoperative pain therapeutics market?
  • What was the historical value and what is the forecasted value of the postoperative pain therapeutics market?
  • What are the key product level trends in the postoperative pain therapeutics market?
  • What are the market level trends in the postoperative pain therapeutics market?
  • Which of the market players are leading and what are their key differential strategies to retain their stronghold?
  • Which are the most lucrative regions in the postoperative pain therapeutics market space?

Postoperative Pain Therapeutics Market - Research Methodology

The report on the postoperative pain therapeutics market is based on an extensive and meticulous bottom up approach, which was used to determine the market size. Total number of surgical procedures were mapped across countries and number of surgeries requiring postoperative pain management were analyzed and estimated.

In the primary phase of the research methodology for the postoperative pain therapeutics market, key stakeholders, including CEOs, presidents, vice presidents, chief medical officers, and product/sales/marketing managers were interviewed for the purpose of garnering unique insights into the dynamics of the postoperative pain therapeutics market. In addition, around 41% of the primary research and analysis was carried out with hospitals/specialty clinics, medical assistants, surgeons, physicians, and pharmacists.

For the secondary phase, prominent sources such as the American Society of Regional Anesthesia and Pain Medicine, American Academy of Pain Medicine, Chronic Pain Association of Canada, Center for Disease Control & Prevention (CDC), National Institutes of Health (NIH), and others were referred to for garnering authentic data with the highest credibility.

Some of the prominent players profiled in the postoperative pain therapeutics market report are-

  • Mallinckrodt Pharmaceuticals
  • Trevena, Inc.
  • Heron Therapeutics
  • Pacira BioSciences, Inc.
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly & Company
  • Mallinckrodt Pharmaceuticals
  • Bayer AG
  • Novartis AG
  • Camarus
Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Postoperative Pain Therapeutics Market

4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Postoperative Pain Therapeutics Market Analysis and Forecast, 2017-2027
4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook
5.1. Regulatory Scenario Assessment
5.2. Overview of Total Surgical Procedures Requiring Postoperative Pain Management
5.3. Pipeline Analysis
5.4. Healthcare industry Overview

6. Global Postoperative Pain Therapeutics Market Analysis and Forecast, by Drug Class
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Drug Class, 2017-2027
6.3.1. Opioids
6.3.2. NSAIDS
6.3.3. Tricyclic Antidepressants
6.3.4. Antiepileptic Drugs
6.3.5. Local Anesthetics
6.3.6. Others
6.4. Market Attractiveness, by Drug Class

7. Global Postoperative Pain Therapeutics Market Analysis and Forecast, by Mode of Administration
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Mode of Administration, 2017-2027
7.3.1. Oral
7.3.2. Intravenous
7.3.3. Intramuscular
7.3.4. Others
7.4. Market Attractiveness, by Mode of Administration

8. Global Postoperative Pain Therapeutics Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Distribution Channel, 2017-2027
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.3.4. Others
8.4. Market Attractiveness, by Distribution Channel

9. Global Postoperative Pain Therapeutics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Country/Region

10. North America Postoperative Pain Therapeutics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Drug Class, 2017-2027
10.2.1. Opioids
10.2.2. NSAIDS
10.2.3. Tricyclic Antidepressants
10.2.4. Antiepileptic Drugs
10.2.5. Local Anesthetics
10.2.6. Others
10.3. Market Value Forecast, by Mode of Administration, 2017-2027
10.3.1. Oral
10.3.2. Intravenous
10.3.3. Intramuscular
10.3.4. Others
10.4. Market Value Forecast, by Distribution Channel, 2017-2027
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017-2027
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Drug Class
10.6.2. By Mode of Administration
10.6.3. By Distribution Channel
10.6.4. By Country

11. Europe Postoperative Pain Therapeutics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Drug Class, 2017-2027
11.2.1. Opioids
11.2.2. NSAIDS
11.2.3. Tricyclic Antidepressants
11.2.4. Antiepileptic Drugs
11.2.5. Local Anesthetics
11.2.6. Others
11.3. Market Value Forecast, by Mode of Administration, 2017-2027
11.3.1. Oral
11.3.2. Intravenous
11.3.3. Intramuscular
11.3.4. Others
11.4. Market Value Forecast, by Distribution Channel, 2017-2027
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Drug Class
11.6.2. By Mode of Administration
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region

12. Asia Pacific Postoperative Pain Therapeutics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Drug Class, 2017-2027
12.2.1. Opioids
12.2.2. NSAIDS
12.2.3. Tricyclic Antidepressants
12.2.4. Antiepileptic Drugs
12.2.5. Local Anesthetics
12.2.6. Others
12.3. Market Value Forecast, by Mode of Administration, 2017-2027
12.3.1. Oral
12.3.2. Intravenous
12.3.3. Intramuscular
12.3.4. Others
12.4. Market Value Forecast, by Distribution Channel, 2017-2027
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Drug Class
12.6.2. By Mode of Administration
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region

13. Latin America Postoperative Pain Therapeutics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Drug Class, 2017-2027
13.2.1. Opioids
13.2.2. NSAIDS
13.2.3. Tricyclic Antidepressants
13.2.4. Antiepileptic Drugs
13.2.5. Local Anesthetics
13.2.6. Others
13.3. Market Value Forecast, by Mode of Administration, 2017-2027
13.3.1. Oral
13.3.2. Intravenous
13.3.3. Intramuscular
13.3.4. Others
13.4. Market Value Forecast, by Distribution Channel, 2017-2027
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017-2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Drug Class
13.6.2. By Mode of Administration
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region

14. Middle East & Africa Postoperative Pain Therapeutics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Drug Class, 2017-2027
14.2.1. Opioids
14.2.2. NSAIDS
14.2.3. Tricyclic Antidepressants
14.2.4. Antiepileptic Drugs
14.2.5. Local Anesthetics
14.2.6. Others
14.3. Market Value Forecast, by Mode of Administration, 2017-2027
14.3.1. Oral
14.3.2. Intravenous
14.3.3. Intramuscular
14.3.4. Others
14.4. Market Value Forecast, by Distribution Channel, 2017-2027
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Drug Class
14.6.2. By Mode of Administration
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region

15. Company Profiles
15.1. Mallinckrodt Pharmaceuticals
15.2. Pacira BioSciences, Inc.
15.3. Trevena, Inc.
15.4. Heron Therapeutics
15.5. Pfizer, Inc.
15.6. Teva Pharmaceutical Industries Ltd.
15.7. Novartis AG
15.8. Camarus
15.9. Eli Lilly & Company
15.10. Mallinckrodt Pharmaceuticals
15.11. Bayer AG
15.12. Others
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll